Correlation between Ultrasonographic Grading of Fatty Liver and Lipid Profile
Keywords:fatty liver disease, ultrasonography, lipid profile
Fatty liver disease can easily cause detrimental changes when it slolwly progressess towards the aggressive stages of liver fibrosis leading to cirrhosis, and it can also cause collateral damages in the form of cardiovascular diseases and atherosclerotic disease. The main purpose of this study is to analyze the correlation between the grading of fatty liver disease provided by the ultrasound with lipid profile work of the affected patient. A comparative analytical study was conducted on 138 patients affected with fatty liver disease,the patients were chosen by convenient sampling technique. Study was conducted at Radiology Department of General Hospital Lahore and Sheikh Zayed Hospital Rahimyar khan during July 2019 to October 2019. Total 138 patients data were analyzed. Out of 138 males were 65 (47.1%) males and females were 73 (52.9%) w.The study indicated that the total number of patients having grade 1 fatty liver was 84 (60.9%), patients having grade 2 fatty liver was 52 (37.7%) and patients having grade 3 fatty liver was 2 (1.4%). Out of 138 patients there were total 67 (48.6%)cases of patients with fatty liver disease and out of 138 patients, 71 (51.4%) were considered normal .Female patients were allegedly found to be more effected with fatty liver than males and majority of patients fell into the category of grade1 fatty liver. Since the majority of the patient fell into the category of grade 1 of fatty liver disese and there lipid profile test also indicated towards normal values so the risk of developing any cardiovascular disease among the patients was mininal.
. J. M. Kneeman, J. Misdraji, and K. E. Corey, “Secondary causes of nonalcoholic fatty liver disease,” Therapeutic Advances in Gastroenterology, vol. 5, no. 3. SAGE Publications, pp. 199–207, 2012.
. “Prevalence and identification of fatty liver (FL) risk markers in local Pakistani population | Abstract.” [Online]. Available: http://www.jocpr.com/abstract/prevalence-and-identification-of-fatty-liver-fl-risk-markers-in-local-pakistani-population-6161.html. [Accessed: 24-Jun-2020].
. “Non-alcoholic Fatty Liver Disease: A Practical Approach to Diagnosis and Staging - PubMed.” [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/25018867/. [Accessed: 24-Jun-2020].
. “Fatty Liver: Yet Another Silent Killer - PubMed.” [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/25358204/. [Accessed: 24-Jun-2020].
. J. K. Dyson, Q. M. Anstee, and S. McPherson, “Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging,” Frontline Gastroenterol., vol. 5, no. 3, pp. 211–218, Jul. 2014.
. “(PDF) Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation.” [Online]. Available: https://www.researchgate.net/publication/51505884_Nonalcoholic_Fatty_Liver_Disease_Focus_on_Lipoprotein_and_Lipid_Deregulation. [Accessed: 24-Jun-2020].
. L. A. Adams and Q. M. Anstee, “A fatty liver leads to a broken heart?,” Journal of Hepatology, vol. 65, no. 1. Elsevier B.V., pp. 14–16, 01-Jul-2016.
. S. M. Abd El-Kader and E. M. S. El-Den Ashmawy, “Non-alcoholic fatty liver disease: The diagnosis and management,” World J. Hepatol., vol. 7, no. 6, pp. 846–858, 2015.
. “Epidemiology of fatty liver: An update | Request PDF.” [Online]. Available: https://www.researchgate.net/publication/264434399_Epidemiology_of_fatty_liver_An_update. [Accessed: 24-Jun-2020].
. R. Hernaez et al., “Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis,” Hepatology, vol. 54, no. 3. NIH Public Access, pp. 1082–1090, 02-Sep-2011.
. A. Qayyum et al., “Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?,” Clin. Imaging, vol. 33, no. 2, pp. 110–115, Mar. 2009.
. A. R. El-Zayadi, “Hepatic steatosis: A benign disease or a silent killer,” World Journal of Gastroenterology, vol. 14, no. 26. Baishideng Publishing Group Inc, pp. 4120–4126, 2008.
. C. Das, M. Baruah, and D. Singh, “Imaging of non alcoholic fatty liver disease: A road less travelled,” Indian J. Endocrinol. Metab., vol. 17, no. 6, p. 990, 2013.
. D. H. Lee, “Imaging evaluation of non-alcoholic fatty liver disease: Focused on quantification,” Clinical and Molecular Hepatology, vol. 23, no. 4. Korean Association for the Study of the Liver, pp. 290–301, 01-Dec-2017.
. M. Hegazy and A. Mostafa, “Liver ultrasound scanning in the detection of hepatic steatosis and fibrosis in NASH patients,” Egypt. J. Intern. Med., vol. 24, no. 2, pp. 27–31, 2012.
. A. Kotronen and H. Yki-Järvinen, “Fatty liver: A novel component of the metabolic syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 1. Arterioscler Thromb Vasc Biol, pp. 27–38, Jan-2008.
. M. Basaranoglu and B. A. Neuschwander-Tetri, “Nonalcoholic fatty liver disease: Clinical features and pathogenesis,” Gastroenterology and Hepatology, vol. 2, no. 4. Millenium Medical Publishing, pp. 282–291, Apr-2006.
. M. Ahmed, “Non-alcoholic fatty liver disease in 2015,” World Journal of Hepatology, vol. 7, no. 11. Baishideng Publishing Group Co, pp. 1450–1459, 2015.
. D. U. Mahaling, M. M. Basavaraj, and A. J. Bika, “Comparison of lipid profile in different grades of non-alcoholic fatty liver disease diagnosed on ultrasound,” Asian Pac. J. Trop. Biomed., vol. 3, no. 11, p. 907, 2013.
. “PREVALENCE OF METABOLIC RISK FACTORS IN NON-ALCOHOLIC FATTY LIVER DISEASE | Pakistan Armed Forces Medical Journal.” [Online]. Available: https://www.pafmj.org/index.php/PAFMJ/article/view/387. [Accessed: 24-Jun-2020].
. R. A. Ghani, M. Saqlain, M. M. Zafar, S. Jabeen, S. M. S. Naqvi, and G. K. Raja, “Identification of metabolic risk phenotypes predisposing to non-alcoholic fatty liver disease in a Pakistani Cohort,” Pakistan J. Med. Sci., vol. 33, no. 1, pp. 121–126, Jan. 2017.
. S. K. Sarin et al., “Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission,” The Lancet Gastroenterology and Hepatology, vol. 5, no. 2. Elsevier Ltd, pp. 167–228, 01-Feb-2020.
. B. Mal Tanwani, A. Ali Jamali, G. Mustafa Jamali, A. Ali Jamali, and M. Ali Sohail, “Non Alcoholic Fatty Liver Disease: Assessment of Lipid Profile Estimation in Different Grades of Fatty Liver on Ultrasound,” Open J. Prev. Med., vol. 8, pp. 70–83, 2018.
. Y.-J. Zhou, “Prevalence of fatty liver disease and its risk factors in the population of South China,” World J. Gastroenterol., vol. 13, no. 47, p. 6419, Dec. 2007.
. C. W. Chon et al., “Effect of nonalcoholic fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic Korean men,” Gut Liver, vol. 6, no. 3, pp. 368–373, Jul. 2012.
How to Cite
Authors who submit papers with this journal agree to the following terms.